Inflammation

Dupilumab improved outcomes among patients with severe chronic rhinosinusitis with nasal polyps across a range of type 2 inflammatory signatures, according to data presented at EAACI Hybrid Congress 2023 in Hamburg, Germany.

WASHINGTON — At 52 weeks, adults with moderate/severe COPD and type 2 inflammation receiving dupilumab had a lower exacerbation rate and better lung function, according to an American Thoracic Society International Conference presentation.

A 0.5 mg dose of colchicine, a drug commonly used for conditions such as gout, was recently approved by the FDA to prevent cardiovascular events in patients with residual inflammatory risk.

Digestive Disease Week 2023 in Chicago may have ended in early May, but Healio coverage has continued all month long. Wondering what you missed and what is coming next? Healio recaps the biggest meeting news making waves in the specialty.

In this Healio | Cardiology Today video exclusive, Daniel Soffer, MD, FNLA, discussed some of the highlights so far from the National Lipid Association Scientific Sessions.

Gut microbial dysbiosis and resulting inflammation may play a role in the development of gestational diabetes mellitus as early as the first trimester of pregnancy, according to a report in Gut.

CHICAGO — In this Healio video exclusive, Paul Feuerstadt, MD, FACG, AGAF, recaps results from a real-world analysis of Zinplava for prevention of recurrent Clostridioides difficile infection in patients with congestive heart failure.

IV allogeneic mesenchymal stromal cells may reduce inflammatory response and thereby reduce the progression of small abdominal aortic aneurysms, a speaker reported.

Higher CT severity scores at hospitalization and 3 months after were linked to poorer lung function in survivors of COVID-19-associated hyperinflammation, according to study results published in BMC Pulmonary Medicine.

Boomerang Medical announced that the first patients have been enrolled in its U.S. clinical trial assessing the use of nerve stimulation as potential treatment for Crohn’s disease and ulcerative colitis.